News

The remarkable timeline of a custom gene-editing therapy to save a newborn
News broke yesterday that researchers in Philadelphia appear to have successfully treated a 6-month-old baby boy, called KJ, ...
Medical Device Network on MSN11h
FDA grants breakthrough device status for Elucent’s EnVisio X1 system
The EnVisio X1 platform is currently under development stage and unavailable for sale or clinical usage in the US.
University of California19h
Biotech’s birthplace: How UCSF sparked a medical renaissance — twice
The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving insulin.